RPRX Financials
Royalty Pharma Plc - Financial statements & key metrics
Stock Price
$62.46
Market Cap
$20.45B
P/E Ratio
23.0
EPS
$1.75
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.26B
Gross Profit
-
Operating Income
-
Net Income
$1.33B
EPS (Diluted)
$1.91
Balance Sheet Highlights
Total Assets
$18.22B
Total Liabilities
$7.88B
Shareholders Equity
-
Cash & Equivalents
$929.03M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$2.77B
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
70.3%
Net Margin
32.6%
ROE
13.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is RPRX revenue?
RPRX's most recent quarterly revenue was $2.26B. Annual revenue can be calculated by summing the four most recent quarters.
Is RPRX profitable?
RPRX reported a profit of $1.33B in the most recent quarter. The net profit margin is 32.6%.
What is RPRX market cap?
RPRX has a market capitalization of $20.45B, making it a large-cap stock.
Does RPRX have debt?
View RPRX's balance sheet for debt information.
What is RPRX cash flow?
Cash flow data is available in the full financial statements.